Table 2 SLC39A6 protein expression during cancer progression by IHC analysis in Chinese Han population
From: SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma
Cancer progression | Immunostaining | P value | |
|---|---|---|---|
Low | High | ||
Normal esophageal epitheliumâ‘ | 113 (85.61) | 19 (14.39) | â‘ :â‘¡P < 0.001; â‘ :â‘¢P < 0.001 |
Low grade intraepithelial neoplasiaâ‘¡ | 39 (48.15) | 42 (51.85) | â‘¡:â‘¢P = 0.004; â‘¡:â‘£P = 0.037, |
High grade intraepithelial neoplasiaâ‘¢ | 12 (23.08) | 40 (76.92) | â‘¢:â‘£P = 0.179 |
ESCCâ‘£ | 47 (33.10) | 95 (66.90) | â‘ :â‘£P < 0.001 |